The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease
We evaluated the effect of beta blockers on thallium-201 (Tl-201) single photon emission computed tomographic (SPECT) imaging in 12 patients with coronary disease using an automated computer algorithm. Maximal exercise heart rate and blood pressure were reduced and exercise time was increased with b...
Gespeichert in:
| Veröffentlicht in: | Am. Heart J.; (United States) 1989-05, Vol.117 (5), p.1030-1035 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1035 |
|---|---|
| container_issue | 5 |
| container_start_page | 1030 |
| container_title | Am. Heart J.; (United States) |
| container_volume | 117 |
| creator | Narahara, Kenneth A. Thompson, Craig J. Hazen, James F. Brizendine, Marianne Mena, Ismael |
| description | We evaluated the effect of beta blockers on thallium-201 (Tl-201) single photon emission computed tomographic (SPECT) imaging in 12 patients with coronary disease using an automated computer algorithm. Maximal exercise heart rate and blood pressure were reduced and exercise time was increased with beta blockers. Estimated stress defect size decreased from 47 ± 36.3 gm during placebo treatment to 32 ± 27.1 gm during beta blocker therapy (−32%;
p < 0.01). The placebo treatment redistribution defect was estimated to be 28 ± 29.8 gm. It fell to 15 ± 23.3 gm with beta blockade (−46%;
p < 0.005). All patients had a stress Tl-201 defect during placebo treatment and eight had redistribution defects consistent with residual scar. During beta blocker therapy, 2 of 12 patients had normal stress-redistribution studies and only five patients had redistribution defects. Beta blockade can reduce exercise and redistribution Tl-201 SPECT defect size significantly while simultaneously increasing exercise time and reducing angina. Beta blockers may unmask or may eliminate evidence of redistribution. Tl-201 SPECT imaging may be useful in defining the reduction in ischemia produced by cardiac drugs. |
| doi_str_mv | 10.1016/0002-8703(89)90858-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_miscellaneous_78938105</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0002870389908582</els_id><sourcerecordid>78938105</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-26c7a6ba89a24e12335fc2adeb48944b4b497f8bce544a4de12b6ce0e80e18583</originalsourceid><addsrcrecordid>eNp9kV2L1TAQhoMo69mj_0AhiCy7F9U0TfNxI8hh_YAFBY_XIU2np9G26Sapsv_An23qOZxLycVkmGeGeedF6EVJ3pSk5G8JIbSQglTXUt0oImtZ0EdoUxIlCi4Ye4w2Z-QpuozxR045lfwCXdCa11zSDfqz7wFD14FN2He4gWRwM3j707SA_YSjmw4D4Ln3KWcwuhhd_lg_zkuCFic_-kMwc-8svv729Xa3v8GpN8PglrGgpMRuNAeI2E14NsnBlCL-7VKfJwQ_mfCAWxfBRHiGnnRmiPD8FLfo-4fb_e5Tcffl4-fd-7vCVrVIBeVWGN4YqQxlUNKqqjtL87INk4qxJj8lOtlYqBkzrM1Iwy0QkATKfKJqi14d5_qYnI7WJbC99dOUL6A5EZUSK3R1hObg7xeISWfhFobBTOCXqIVUlSxJnUF2BG3wMQbo9Byy4vCgS6JXl_RqgV4t0FLpfy5pmttenuYvzQjtuelkS66_PtVNtGbogpmsi2dMUKFUlr5F744Y5IP9chBWPTBZaF1Y5bTe_X-Pv8qKroo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78938105</pqid></control><display><type>article</type><title>The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Narahara, Kenneth A. ; Thompson, Craig J. ; Hazen, James F. ; Brizendine, Marianne ; Mena, Ismael</creator><creatorcontrib>Narahara, Kenneth A. ; Thompson, Craig J. ; Hazen, James F. ; Brizendine, Marianne ; Mena, Ismael ; Harbor-UCLA Medical Center, Torrance (USA)</creatorcontrib><description>We evaluated the effect of beta blockers on thallium-201 (Tl-201) single photon emission computed tomographic (SPECT) imaging in 12 patients with coronary disease using an automated computer algorithm. Maximal exercise heart rate and blood pressure were reduced and exercise time was increased with beta blockers. Estimated stress defect size decreased from 47 ± 36.3 gm during placebo treatment to 32 ± 27.1 gm during beta blocker therapy (−32%;
p < 0.01). The placebo treatment redistribution defect was estimated to be 28 ± 29.8 gm. It fell to 15 ± 23.3 gm with beta blockade (−46%;
p < 0.005). All patients had a stress Tl-201 defect during placebo treatment and eight had redistribution defects consistent with residual scar. During beta blocker therapy, 2 of 12 patients had normal stress-redistribution studies and only five patients had redistribution defects. Beta blockade can reduce exercise and redistribution Tl-201 SPECT defect size significantly while simultaneously increasing exercise time and reducing angina. Beta blockers may unmask or may eliminate evidence of redistribution. Tl-201 SPECT imaging may be useful in defining the reduction in ischemia produced by cardiac drugs.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/0002-8703(89)90858-2</identifier><identifier>PMID: 2565682</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics ; Adrenergic beta-Agonists - pharmacology ; Adrenergic beta-Agonists - therapeutic use ; ALGORITHMS ; AUTONOMIC NERVOUS SYSTEM AGENTS ; BETA DECAY RADIOISOTOPES ; Betaxolol ; Biological and medical sciences ; BIOLOGICAL EFFECTS ; BLOOD PRESSURE ; Blood Pressure - drug effects ; BODY ; CARDIOVASCULAR DISEASES ; CARDIOVASCULAR SYSTEM ; COMPUTERIZED TOMOGRAPHY ; Coronary Disease - diagnostic imaging ; Coronary Disease - drug therapy ; Coronary Disease - physiopathology ; DAYS LIVING RADIOISOTOPES ; DIAGNOSIS ; DIAGNOSTIC TECHNIQUES ; DISEASES ; DRUGS ; ELECTRON CAPTURE RADIOISOTOPES ; EMISSION COMPUTED TOMOGRAPHY ; EXERCISE ; Female ; HEART ; Heart Rate - drug effects ; HEAVY NUCLEI ; Humans ; ISOMERIC TRANSITION ISOTOPES ; ISOTOPES ; Male ; MATHEMATICAL LOGIC ; Medical sciences ; Miscellaneous ; NUCLEI ; ODD-EVEN NUCLEI ; ORGANS ; PATIENTS ; Pharmacology. Drug treatments ; Propanolamines - pharmacology ; Propanolamines - therapeutic use ; Propranolol - pharmacology ; Propranolol - therapeutic use ; RADIOISOTOPES ; RADIOLOGY AND NUCLEAR MEDICINE ; SECONDS LIVING RADIOISOTOPES ; SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY ; SYMPATHOLYTICS ; THALLIUM 201 ; THALLIUM ISOTOPES ; Thallium Radioisotopes ; TOMOGRAPHY ; Tomography, Emission-Computed</subject><ispartof>Am. Heart J.; (United States), 1989-05, Vol.117 (5), p.1030-1035</ispartof><rights>1989</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-26c7a6ba89a24e12335fc2adeb48944b4b497f8bce544a4de12b6ce0e80e18583</citedby><cites>FETCH-LOGICAL-c357t-26c7a6ba89a24e12335fc2adeb48944b4b497f8bce544a4de12b6ce0e80e18583</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0002-8703(89)90858-2$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,881,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7279923$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2565682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/6073978$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Narahara, Kenneth A.</creatorcontrib><creatorcontrib>Thompson, Craig J.</creatorcontrib><creatorcontrib>Hazen, James F.</creatorcontrib><creatorcontrib>Brizendine, Marianne</creatorcontrib><creatorcontrib>Mena, Ismael</creatorcontrib><creatorcontrib>Harbor-UCLA Medical Center, Torrance (USA)</creatorcontrib><title>The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease</title><title>Am. Heart J.; (United States)</title><addtitle>Am Heart J</addtitle><description>We evaluated the effect of beta blockers on thallium-201 (Tl-201) single photon emission computed tomographic (SPECT) imaging in 12 patients with coronary disease using an automated computer algorithm. Maximal exercise heart rate and blood pressure were reduced and exercise time was increased with beta blockers. Estimated stress defect size decreased from 47 ± 36.3 gm during placebo treatment to 32 ± 27.1 gm during beta blocker therapy (−32%;
p < 0.01). The placebo treatment redistribution defect was estimated to be 28 ± 29.8 gm. It fell to 15 ± 23.3 gm with beta blockade (−46%;
p < 0.005). All patients had a stress Tl-201 defect during placebo treatment and eight had redistribution defects consistent with residual scar. During beta blocker therapy, 2 of 12 patients had normal stress-redistribution studies and only five patients had redistribution defects. Beta blockade can reduce exercise and redistribution Tl-201 SPECT defect size significantly while simultaneously increasing exercise time and reducing angina. Beta blockers may unmask or may eliminate evidence of redistribution. Tl-201 SPECT imaging may be useful in defining the reduction in ischemia produced by cardiac drugs.</description><subject>550601 - Medicine- Unsealed Radionuclides in Diagnostics</subject><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Adrenergic beta-Agonists - therapeutic use</subject><subject>ALGORITHMS</subject><subject>AUTONOMIC NERVOUS SYSTEM AGENTS</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>Betaxolol</subject><subject>Biological and medical sciences</subject><subject>BIOLOGICAL EFFECTS</subject><subject>BLOOD PRESSURE</subject><subject>Blood Pressure - drug effects</subject><subject>BODY</subject><subject>CARDIOVASCULAR DISEASES</subject><subject>CARDIOVASCULAR SYSTEM</subject><subject>COMPUTERIZED TOMOGRAPHY</subject><subject>Coronary Disease - diagnostic imaging</subject><subject>Coronary Disease - drug therapy</subject><subject>Coronary Disease - physiopathology</subject><subject>DAYS LIVING RADIOISOTOPES</subject><subject>DIAGNOSIS</subject><subject>DIAGNOSTIC TECHNIQUES</subject><subject>DISEASES</subject><subject>DRUGS</subject><subject>ELECTRON CAPTURE RADIOISOTOPES</subject><subject>EMISSION COMPUTED TOMOGRAPHY</subject><subject>EXERCISE</subject><subject>Female</subject><subject>HEART</subject><subject>Heart Rate - drug effects</subject><subject>HEAVY NUCLEI</subject><subject>Humans</subject><subject>ISOMERIC TRANSITION ISOTOPES</subject><subject>ISOTOPES</subject><subject>Male</subject><subject>MATHEMATICAL LOGIC</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>NUCLEI</subject><subject>ODD-EVEN NUCLEI</subject><subject>ORGANS</subject><subject>PATIENTS</subject><subject>Pharmacology. Drug treatments</subject><subject>Propanolamines - pharmacology</subject><subject>Propanolamines - therapeutic use</subject><subject>Propranolol - pharmacology</subject><subject>Propranolol - therapeutic use</subject><subject>RADIOISOTOPES</subject><subject>RADIOLOGY AND NUCLEAR MEDICINE</subject><subject>SECONDS LIVING RADIOISOTOPES</subject><subject>SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY</subject><subject>SYMPATHOLYTICS</subject><subject>THALLIUM 201</subject><subject>THALLIUM ISOTOPES</subject><subject>Thallium Radioisotopes</subject><subject>TOMOGRAPHY</subject><subject>Tomography, Emission-Computed</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kV2L1TAQhoMo69mj_0AhiCy7F9U0TfNxI8hh_YAFBY_XIU2np9G26Sapsv_An23qOZxLycVkmGeGeedF6EVJ3pSk5G8JIbSQglTXUt0oImtZ0EdoUxIlCi4Ye4w2Z-QpuozxR045lfwCXdCa11zSDfqz7wFD14FN2He4gWRwM3j707SA_YSjmw4D4Ln3KWcwuhhd_lg_zkuCFic_-kMwc-8svv729Xa3v8GpN8PglrGgpMRuNAeI2E14NsnBlCL-7VKfJwQ_mfCAWxfBRHiGnnRmiPD8FLfo-4fb_e5Tcffl4-fd-7vCVrVIBeVWGN4YqQxlUNKqqjtL87INk4qxJj8lOtlYqBkzrM1Iwy0QkATKfKJqi14d5_qYnI7WJbC99dOUL6A5EZUSK3R1hObg7xeISWfhFobBTOCXqIVUlSxJnUF2BG3wMQbo9Byy4vCgS6JXl_RqgV4t0FLpfy5pmttenuYvzQjtuelkS66_PtVNtGbogpmsi2dMUKFUlr5F744Y5IP9chBWPTBZaF1Y5bTe_X-Pv8qKroo</recordid><startdate>198905</startdate><enddate>198905</enddate><creator>Narahara, Kenneth A.</creator><creator>Thompson, Craig J.</creator><creator>Hazen, James F.</creator><creator>Brizendine, Marianne</creator><creator>Mena, Ismael</creator><general>Mosby, Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>198905</creationdate><title>The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease</title><author>Narahara, Kenneth A. ; Thompson, Craig J. ; Hazen, James F. ; Brizendine, Marianne ; Mena, Ismael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-26c7a6ba89a24e12335fc2adeb48944b4b497f8bce544a4de12b6ce0e80e18583</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>550601 - Medicine- Unsealed Radionuclides in Diagnostics</topic><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Adrenergic beta-Agonists - therapeutic use</topic><topic>ALGORITHMS</topic><topic>AUTONOMIC NERVOUS SYSTEM AGENTS</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>Betaxolol</topic><topic>Biological and medical sciences</topic><topic>BIOLOGICAL EFFECTS</topic><topic>BLOOD PRESSURE</topic><topic>Blood Pressure - drug effects</topic><topic>BODY</topic><topic>CARDIOVASCULAR DISEASES</topic><topic>CARDIOVASCULAR SYSTEM</topic><topic>COMPUTERIZED TOMOGRAPHY</topic><topic>Coronary Disease - diagnostic imaging</topic><topic>Coronary Disease - drug therapy</topic><topic>Coronary Disease - physiopathology</topic><topic>DAYS LIVING RADIOISOTOPES</topic><topic>DIAGNOSIS</topic><topic>DIAGNOSTIC TECHNIQUES</topic><topic>DISEASES</topic><topic>DRUGS</topic><topic>ELECTRON CAPTURE RADIOISOTOPES</topic><topic>EMISSION COMPUTED TOMOGRAPHY</topic><topic>EXERCISE</topic><topic>Female</topic><topic>HEART</topic><topic>Heart Rate - drug effects</topic><topic>HEAVY NUCLEI</topic><topic>Humans</topic><topic>ISOMERIC TRANSITION ISOTOPES</topic><topic>ISOTOPES</topic><topic>Male</topic><topic>MATHEMATICAL LOGIC</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>NUCLEI</topic><topic>ODD-EVEN NUCLEI</topic><topic>ORGANS</topic><topic>PATIENTS</topic><topic>Pharmacology. Drug treatments</topic><topic>Propanolamines - pharmacology</topic><topic>Propanolamines - therapeutic use</topic><topic>Propranolol - pharmacology</topic><topic>Propranolol - therapeutic use</topic><topic>RADIOISOTOPES</topic><topic>RADIOLOGY AND NUCLEAR MEDICINE</topic><topic>SECONDS LIVING RADIOISOTOPES</topic><topic>SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY</topic><topic>SYMPATHOLYTICS</topic><topic>THALLIUM 201</topic><topic>THALLIUM ISOTOPES</topic><topic>Thallium Radioisotopes</topic><topic>TOMOGRAPHY</topic><topic>Tomography, Emission-Computed</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Narahara, Kenneth A.</creatorcontrib><creatorcontrib>Thompson, Craig J.</creatorcontrib><creatorcontrib>Hazen, James F.</creatorcontrib><creatorcontrib>Brizendine, Marianne</creatorcontrib><creatorcontrib>Mena, Ismael</creatorcontrib><creatorcontrib>Harbor-UCLA Medical Center, Torrance (USA)</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Am. Heart J.; (United States)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Narahara, Kenneth A.</au><au>Thompson, Craig J.</au><au>Hazen, James F.</au><au>Brizendine, Marianne</au><au>Mena, Ismael</au><aucorp>Harbor-UCLA Medical Center, Torrance (USA)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease</atitle><jtitle>Am. Heart J.; (United States)</jtitle><addtitle>Am Heart J</addtitle><date>1989-05</date><risdate>1989</risdate><volume>117</volume><issue>5</issue><spage>1030</spage><epage>1035</epage><pages>1030-1035</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>We evaluated the effect of beta blockers on thallium-201 (Tl-201) single photon emission computed tomographic (SPECT) imaging in 12 patients with coronary disease using an automated computer algorithm. Maximal exercise heart rate and blood pressure were reduced and exercise time was increased with beta blockers. Estimated stress defect size decreased from 47 ± 36.3 gm during placebo treatment to 32 ± 27.1 gm during beta blocker therapy (−32%;
p < 0.01). The placebo treatment redistribution defect was estimated to be 28 ± 29.8 gm. It fell to 15 ± 23.3 gm with beta blockade (−46%;
p < 0.005). All patients had a stress Tl-201 defect during placebo treatment and eight had redistribution defects consistent with residual scar. During beta blocker therapy, 2 of 12 patients had normal stress-redistribution studies and only five patients had redistribution defects. Beta blockade can reduce exercise and redistribution Tl-201 SPECT defect size significantly while simultaneously increasing exercise time and reducing angina. Beta blockers may unmask or may eliminate evidence of redistribution. Tl-201 SPECT imaging may be useful in defining the reduction in ischemia produced by cardiac drugs.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>2565682</pmid><doi>10.1016/0002-8703(89)90858-2</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-8703 |
| ispartof | Am. Heart J.; (United States), 1989-05, Vol.117 (5), p.1030-1035 |
| issn | 0002-8703 1097-6744 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78938105 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | 550601 - Medicine- Unsealed Radionuclides in Diagnostics Adrenergic beta-Agonists - pharmacology Adrenergic beta-Agonists - therapeutic use ALGORITHMS AUTONOMIC NERVOUS SYSTEM AGENTS BETA DECAY RADIOISOTOPES Betaxolol Biological and medical sciences BIOLOGICAL EFFECTS BLOOD PRESSURE Blood Pressure - drug effects BODY CARDIOVASCULAR DISEASES CARDIOVASCULAR SYSTEM COMPUTERIZED TOMOGRAPHY Coronary Disease - diagnostic imaging Coronary Disease - drug therapy Coronary Disease - physiopathology DAYS LIVING RADIOISOTOPES DIAGNOSIS DIAGNOSTIC TECHNIQUES DISEASES DRUGS ELECTRON CAPTURE RADIOISOTOPES EMISSION COMPUTED TOMOGRAPHY EXERCISE Female HEART Heart Rate - drug effects HEAVY NUCLEI Humans ISOMERIC TRANSITION ISOTOPES ISOTOPES Male MATHEMATICAL LOGIC Medical sciences Miscellaneous NUCLEI ODD-EVEN NUCLEI ORGANS PATIENTS Pharmacology. Drug treatments Propanolamines - pharmacology Propanolamines - therapeutic use Propranolol - pharmacology Propranolol - therapeutic use RADIOISOTOPES RADIOLOGY AND NUCLEAR MEDICINE SECONDS LIVING RADIOISOTOPES SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY SYMPATHOLYTICS THALLIUM 201 THALLIUM ISOTOPES Thallium Radioisotopes TOMOGRAPHY Tomography, Emission-Computed |
| title | The effect of beta blockade on single photon emission computed tomographic (SPECT) thallium-201 images in patients with coronary disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T17%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20beta%20blockade%20on%20single%20photon%20emission%20computed%20tomographic%20(SPECT)%20thallium-201%20images%20in%20patients%20with%20coronary%20disease&rft.jtitle=Am.%20Heart%20J.;%20(United%20States)&rft.au=Narahara,%20Kenneth%20A.&rft.aucorp=Harbor-UCLA%20Medical%20Center,%20Torrance%20(USA)&rft.date=1989-05&rft.volume=117&rft.issue=5&rft.spage=1030&rft.epage=1035&rft.pages=1030-1035&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/0002-8703(89)90858-2&rft_dat=%3Cproquest_osti_%3E78938105%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78938105&rft_id=info:pmid/2565682&rft_els_id=0002870389908582&rfr_iscdi=true |